232 related articles for article (PubMed ID: 24919751)
1. Novel urinary biomarkers in early diabetic kidney disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Curr Diab Rep; 2014 Aug; 14(8):513. PubMed ID: 24919751
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.
Liang X; Wang P; Chen B; Ge Y; Gong AY; Flickinger B; Malhotra DK; Wang LJ; Dworkin LD; Liu Z; Gong R
Kidney Int; 2020 Jan; 97(1):175-192. PubMed ID: 31791666
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.
Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordström J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nyström J; Wernerson A
Nephrol Dial Transplant; 2020 Dec; 35(12):2059-2072. PubMed ID: 32853351
[TBL] [Abstract][Full Text] [Related]
6. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
[TBL] [Abstract][Full Text] [Related]
7. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease.
De Carvalho JA; Tatsch E; Hausen BS; Londero SW; Comim FV; Moresco RN
Clin Chem Lab Med; 2016 Mar; 54(3):e85-8. PubMed ID: 26402882
[No Abstract] [Full Text] [Related]
8. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
Grove KJ; Lareau NM; Voziyan PA; Zeng F; Harris RC; Hudson BG; Caprioli RM
Kidney Int; 2018 Aug; 94(2):292-302. PubMed ID: 29779708
[TBL] [Abstract][Full Text] [Related]
9. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
10. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
Satirapoj B; Pooluea P; Nata N; Supasyndh O
J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
[TBL] [Abstract][Full Text] [Related]
11. Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.
Gerritsen KG; Leeuwis JW; Koeners MP; Bakker SJ; van Oeveren W; Aten J; Tarnow L; Rossing P; Wetzels JF; Joles JA; Kok RJ; Goldschmeding R; Nguyen TQ
J Diabetes Res; 2015; 2015():539787. PubMed ID: 26171399
[TBL] [Abstract][Full Text] [Related]
12. Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases.
Wei Z; Kwan BC; Chow KM; Cheng PM; Luk CC; Lai KB; Li PK; Szeto CC
BMC Nephrol; 2018 Dec; 19(1):367. PubMed ID: 30567508
[TBL] [Abstract][Full Text] [Related]
13. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
[TBL] [Abstract][Full Text] [Related]
14. Urinary exosomes: Potential biomarkers for diabetic nephropathy.
Sinha N; Kumar V; Puri V; Nada R; Rastogi A; Jha V; Puri S
Nephrology (Carlton); 2020 Dec; 25(12):881-887. PubMed ID: 32323449
[TBL] [Abstract][Full Text] [Related]
15. Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury.
Kanauchi M; Nishioka M; Dohi K
Diabetologia; 2000 Aug; 43(8):1076-7. PubMed ID: 10990088
[No Abstract] [Full Text] [Related]
16. Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.
Wu CY; Yang HY; Chien HP; Tseng MH; Huang JL
Pediatr Nephrol; 2018 Jul; 33(7):1189-1198. PubMed ID: 29511890
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
18. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
19. Urinary liver type fatty acid binding protein in diabetic nephropathy.
Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
[TBL] [Abstract][Full Text] [Related]
20. Urinary proteomics in diabetes and CKD.
Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
